The Clinical Course of Breast Cancer: A Psychological Perspective1

2015 ◽  
pp. 133-145 ◽  
Author(s):  
Jimmie Holland
Keyword(s):  
Breast Cancer ◽  
Clinical Course

Clinical Course of Breast Cancer Patients with Local-Regional Progression During Neoadjuvant Systemic Therapy

2021 ◽  
Author(s):  
Leisha C. Elmore ◽  
Henry M. Kuerer ◽  
Carlos H. Barcenas ◽  
Benjamin D. Smith ◽  
Makesha V. Miggins ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Cancer Patients ◽  
Systemic Therapy ◽  
Clinical Course ◽  
Breast Cancer Patients ◽  
Neoadjuvant Systemic Therapy

Metastatic breast cancer: clinical course, prognosis and therapy related to the first site of metastasis

2000 ◽  
Vol 59 (3) ◽  
pp. 271-278 ◽  
Author(s):  
E.-F. Solomayer ◽  
I.J. Diel ◽  
G.C. Meyberg ◽  
Ch. Gollan ◽  
G. Bastert
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Clinical Course ◽  
Metastatic Breast

scholarly journals A CASE OF NODULAR FASCIITIS OF THE PECTORALIS MAJOR MUSCLE FOLLOWING A LONG-TERM CLINICAL COURSE AND MASQUERADING BREAST CANCER

2009 ◽  
Vol 70 (11) ◽  
pp. 3263-3266 ◽  
Author(s):  
Takeshi YAMAGIWA ◽  
Takayuki TAJIMA ◽  
Masato NAKAMURA ◽  
Masaya MUKAI ◽  
Sadaki INOKUCHI ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Clinical Course ◽  
Pectoralis Major Muscle ◽  
Pectoralis Major ◽  
Nodular Fasciitis

scholarly journals Serologic Concentrations of HER-2/neu in Breast Cancer Patients with Visceral Metastases Receiving Trastuzumab Therapy Predict the Clinical Course

2002 ◽  
Vol 48 (8) ◽  
pp. 1360-1362 ◽  
Author(s):  
Thomas Schöndorf ◽  
Markus Hoopmann ◽  
Mathias Warm ◽  
Rainer Neumann ◽  
Anke Thomas ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Cancer Patients ◽  
Clinical Course ◽  
Breast Cancer Patients ◽  
Trastuzumab Therapy ◽  
Visceral Metastases ◽  
Her 2

scholarly journals The clinical course of bone metastases from breast cancer

1987 ◽  
Vol 55 (1) ◽  
pp. 61-66 ◽  
Author(s):  
RE Coleman ◽  
RD Rubens
Keyword(s):  
Breast Cancer ◽  
Bone Metastases ◽  
Clinical Course

scholarly journals Importance of Copy Number Alterations of FGFR1 and C-MYC Genes in Triple Negative Breast Cancer

2018 ◽  
Vol 0 (0) ◽  
Author(s):  
Milica Nedeljković ◽  
Nikola Tanić ◽  
Tatjana Dramićanin ◽  
Zorka Milovanović ◽  
Snežana Šušnjar ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Prognostic Marker ◽  
Triple Negative Breast Cancer ◽  
Copy Number ◽  
Triple Negative ◽  
Clinical Course ◽  
Copy Number Gain ◽  
Gene Copy ◽  
Copy Number Alterations ◽  
The Impact

Summary Background: Triple negative breast cancer (TNBC) is characterized by aggressive clinical course and is unresponsive to anti-HER2 and endocrine therapy. TNBC is difficult to treat and is often lethal. Given the need to find new targets for therapy we explored clinicopathological significance of copy number gain of FGFR1 and c-MYC. Our aim was to determine the impact of FGFR1 and c-MYC copy number gain on clinical course and outcome of TNBC. Methods: FGFR1 and c-MYC gene copy number alterations were evaluated in 78 archive TNBC samples using TaqMan based quantitative real time PCR assays. Results: 50% of samples had increased c-MYC copy number. c-MYC copy number gain was associated with TNBC in contrast to ER positive cancers. Our results showed significant correlation between c-MYC copy number gain and high grade of TNBCs. This suggests that c-MYC copy number could be an useful prognostic marker for TNBC patients. c-MYC copy number gain was associated with high pTNM stage as well as lobular and medullary tumor subtypes. 43% of samples had increased FGFR1 copy number. No correlations between FGFR1 copy number gain and clinicopathological variables were observed. Conclusions: We identified c-MYC copy number gain as a prognostic marker for TNBC. Our results indicate that c- MYC may contribute to TNBC progression. We observed no significant association between c-MYC and/or FGFR1 copy number status and patient survival.

Sign in / Sign up

Export Citation Format

Share Document